Clinical trial
IDEA-033 Open Label Study
NCT00372333 · IDEA AG, Industry · Completed
Key facts
| NCT number | NCT00372333 |
|---|---|
| Title | IDEA-033 Open Label Study |
| Official title | A Multiple-Dose, Open-Label Safety, Compliance, and Usage Evaluation Study of Epicutaneously Applied IDEA-033 in Joint / Musculoskeletal Pain or Soft Tissue Inflammation |
| Lead sponsor | IDEA AG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Joint Pain, Musculoskeletal Pain, Stiffness, Soft Tissue Inflammation in Designated Target Area(s) |
| Intervention type | Drug |
| Interventions | IDEA-033 |
| Enrollment | 491 |
| Start date | Aug 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Sep 6, 2006 |
| Last update posted | Mar 20, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: